Окончание

avk

Архивъ внутренней медицины

The Russian Archives of Internal Medicine

2226-67042411-6564

“SINAPS” LLC

10.20514/2226-6704-2011-0-2-20-24

avk-26

Research Article

ОБЩЕЕ ДЕЛО

Коморбидность в клинической практике

Верткин

А. Л.

Reis

A. B.

кафедра терапии, клинической фармакологии и неотложной помощи

kafedrakf@mail.ru

Румянцев

М. А.

Yakovlev

A. Yu

кафедра терапии, клинической фармакологии и неотложной помощи

Скотников

А. С.

Gushchina

N. N.

кафедра терапии, клинической фармакологии и неотложной помощи

ГОУ ВПО Московский государственный медико-стоматологический университетRussian Federation

2011

28042011

022024

2011

Верткин А.Л., Румянцев М.А., Скотников А.С.

Reis A.B., Yakovlev A.Y., Gushchina N.N.

Данная работа распространяется под лицензией Creative Commons Attribution 4.0.

This work is licensed under a Creative Commons Attribution 4.0 License.

https://www.medarhive.ru/jour/article/view/26

Окончание

Окончание. Начало читайте в журнале «Архивъ внутренней медицины», № 1, 2011, с. 16–20.

References1

Автандилов Г.Г., Зайратьянц О.В., Кактурский Л.В. Оформление диагноза. М., 2004.

Белялов Ф.И. Лечение внутренних болезней в условиях коморбидности. Монография. 2-е изд. Иркутск, 2010.

Верткин А.Л., Зайратьянц О.В., Вовк Е.И. Окончательный диагноз. М., 2008.

Верткин А.Л., Скотников А.С. Роль хронического аллергического воспаления в патогенезе бронхиальной астмы и его рациональная фармакотерапия у пациентов с полипатией // Лечащий врач. 2009. № 4. С. 61–67.

Зайратьянц О.В., Кактурский Л.В. Формулировка и сопоставление клинического и патологоанатомического диагнозов. М., 2008.

Лазебник Л.Б. Полиморбидность и старение // Клин. геронтол. 2005. № 12.

Лазебник Л.Б. Старение и полиморбидность // Consilium Medicum. 2005. № 12.

Лучихин Л.А. Коморбидность в ЛОР-практике // Вестник оториноларингологии. 2010. № 2. С. 79–82.

Нуллер Ю.Л. Обзор психиатрии и мед. психологии. М., 1993.

Смулевич А.Б., Дубницкая Э.Б., Тхостов А.Ш. Депрессии и коморбидные расстройства. М., 1997.

Aronow W.S. Prevalence of CAD, complex ventricular arrhythmias, and silent myocardial ischemia and incidence of new coronary events in older persons with chronic renal insufficiency and with normal renal function // Am. J. Card. 2000. № 86. Р. 1142–1143.

Boyd J.H., Burke J.D. Exclusion criteria of DSM-III: a study of cooccurrence of hierarchy-free syndromes // Arch. Gen. Psychiatry. 1984. № 41. Р. 983–9.

Bruce S.G., Riediger N.D., Zacharias J.M., Young T.K. Obesity and obesityrelated comorbidities in a Canadian First Nation population // Prev. Chronic Dis. 2011.

Carey E.C., Walter L.C., Lindquist K., Covinsky K.E. Development and validation of a functional morbidity index to predict mortality in communitydwelling elders // J. Gen. Intern. Med. 2004. Vol. 19. № 10. Р. 1027–33.

Caughey G.E., Vitry A.I., Gilbert A.L., Roughead E.E. Prevalence of comorbidity of chronic diseases in Australia // BMC Public Health. 2008. № 8. Р. 221.

Charlson M.E., Pompei P., Ales H.L. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation // Journal Chronic Disease. 1987. № 40. Р. 373–383.

Cloninger C.R. Implications of comorbidity for the classification of mental disorders: the need for a psychobiology of coherence // Psychiatric Diagnosis and Classification. 2002. Р. 79–105.

Cuijpers P., van Lammeren P., Duzijn B. Relation between quality of life and chronic illnesses in elderly living in residential homes: a prospective study // Int. Psychogeriatr. 1999. № 11. Р. 445–454.

Daveluy C., Pica L., Audet N. Enquête Sociale et de Santé 1998. 2nd ed. Québec: Institut de la statistique du Québec, 2001.

DCCT Research Group Reliability and validity of a diabetes quality of life measure for the diabetes control and complications trial (DCCT) // Diabetes Care. 1998. № 11. Р. 725–732.

De Groot V., Beckerman H., Lankhorst G.J., Bouter L.M. How to measure comorbidity: a critical review of available methods // J. Clin. Epidemiol. 2003. Vol. 56. № 3. Р. 221–9.

Desai M.M., Bogardus S.T. Jr, Williams C.S. et al. Development and validation of a risk-adjustment index for older patients: the high-risk diagnoses for the elderly scale // J. Am. Geriatr. Soc. 2002. Vol. 50. № 3. Р. 474–81.

Deyo R.A., Cherkin D.C., Ciol M.A. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases // J. Clin. Epidemiol. 1992. Vol. 45. № 6. Р. 613–9.

Feinstein A.R. Pre-therapeutic classification of co-morbidity in chronic disease // Journal Chronic Disease. 1970. Vol. 23. № 7. Р. 455–468.

Feudjo-Tepie M.A., Le Roux G., Beach K.J., Bennett D., Robinson N.J. Comorbidities of Idiopathic Thrombocytopenic Purpura: A Population-Based Study // Advances in Hematology. 2009.

Fortin M., Bravo G., Hudon C. et al. Prevalence of multimorbidity among adults seen in family practice // Ann. Fam. Med. 2005. № 3. Р. 223–8.

Fortin M., Dionne J., Pinho G. et al. Randomized clinical trials: Do they have external validity for patients with multiple comorbidities? // Ann. Fam. Med. 2006. № 4. Р. 104–8.

Fortin M., Lapointe L., Hudon C., Vanasse A. Multimorbidity in medical literature: Is it commonly researched? // Can. Fam. Physician. 2005. № 51. Р. 244–245.

Fortin M., Lapointe L., Hudon C., Vanasse A. Multimorbidity in the medical literature: a bibliometric study // Can. Fam. Physician. 2004.

Fuchs Z., Blumstein T., Novikov I. Morbidity, comorbidity, and their association with disability among community-dwelling oldest in Israel // J. Gerontol. A Biol. Sci. Med. Sci. 1998. Vol. 53A. № 6. Р. M447–M455.

Gijsen R., Hoeymans N., Schellevis F.G., Ruwaard D., Satariano W.A. Causes and consequences of comorbidity: a review // Journal of Clinical Epidemiology. 2001. Vol. 54. Iss. 7. Р. 661–674.

Gill T., Feinstein A.R. A critical appraisal of the quality-of-life measurements // JAMA. 1994. № 272. Р. 619–626.

Greenfield S., Apolone G. The importance of coexistent disease in the occurrence of postoperative complications and one-year recovery in patients undergoing total hip replacement: Comorbidity and outcomes after hip replacement // Med. Care. 1993. № 31. Р. 141–154.

Grimby A., Svanborg A. Morbidity and health-related quality of life among ambulant elderly citizens // Aging. 1997. № 9. Р. 356–364.

Grolla D.L., Tob T., Bombardierc C., Wright J.G. The development of a comorbidity index with physical function as the outcome // Journal of Clinical Epidemiology. 2005. Vol. 58. Iss. 6. Р. 595–602.

Harboun M., Ankri J. Comorbidity indexes: review of the literature and application to the elderly population // Rev. Epidemiol. Sante Publique. 2001. Vol. 49. № 3. Р. 287–98.

Hoffman C., Rice D., Sung H.Y. Persons with chronic conditions. Their prevalence and costs // JAMA. 1996. Vol. 13. № 276 (18). Р. 1473–9.

Jensen I. Proceedings: Pathology and prognostic factors in temporal lobe epilepsy. Follow-up after temporal lobe resection // Acta Neurochir. 1975. Vol. 31. № 3–4. Р. 261–2.

Kaplan M.H., Feinstein A.R. The importance of classifying initial comorbidity in evaluating the outcome of diabetes mellitus // Journal Chronic Disease. 1974. № 27. Р. 387–404.

Kaplan M.H., Feinstein A.R. Acritique of methods in reported studies of long-term vascular complications in patients with diabetes mellitus // Diabetes. 1973. Vol. 22. № 3. Р. 160–174.

Kraemer H.C. Statistical issues in assessing comorbidity // Stat. Med. 1995. № 14. Р. 721–723.

Lee S.J., Lindquist K., Segal M.R., Covinsky K.E. Development and validation of a prognostic index for 4-year mortality in older adults // JAMA. 2006. Vol. 15. № 295. Р. 801–8.

Linn B.S., Linn M.W., Gurel L. Cumulative illness rating scale // J. Amer. Geriatr. Soc. 1968. № 16. Р. 622–626.

Michelson H., Bolund C., Brandberg Y. Multiple chronic health problems are negatively associated with health related quality of life (HRQOL) irrespective of age // Qual. Life Res. 2000. № 9. Р. 1093–1104.

Miller M.D., Paradis C.F., Houck P.R. et al. Rating chronic medical illness burden in geropsychiatric practice and research: application of the Cumulative Illness Rating Scale // Psychiatry Res. 1992. № 41. Р. 237–48.

Miller M.D., Towers A. Manual of Guidelines for Scoring the Cumulative Illness Rating Scale for Geriatrics (CIRS-G). Pittsburg, Pa: University of Pittsburgh, 1991.

Munoz E., Rosner F., Friedman R. et al. Financial risk, hospital cost, complications and comorbidities in medical non-complications and comorbidity-stratified diagnosis-related groups // Am. J. Med. 1988. Vol. 84. № 5. Р. 933–9.

Pincus T., Kallahan L.F. Taking mortality in rheumatoid arthritis seriously: Predictive markers, socioeconomic status and comorbidity // J. Rheumatol. 1996. Vol. 13. P. 841–845.

Robins L. How recognizing comorbidities in psychopathology may lead to an improved research nosology // Clinical Psychology: Science and Practice. 1994. № 1. Р. 93–95.

Rozzini R., Frisoni G.B., Ferrucci L. et al. Geriatric Index of Comorbidity: validation and comparison with other measures of comorbidity // Age Ageing. 2002. Vol. 31. № 4. Р. 277–85.

Sanderson W.C., Beck A.T., Beck J. Syndrome comorbidity in patients with major depression or dysthymia: Prevalence and temporal relationships // Am. J. Psychiatry. 1990. № 147. Р. 1025–1028.

Schellevis F.G., Velden J. vd, Lisdonk E. vd. Comorbidity of chronic diseases in general practice // J. Clin. Epidemiol. 1993. № 46. Р. 469–473.

Starfield B., Lemke K.W., Bernhardt T. Comorbidity: Implications for the Importance of Primary Care in Case Management // Ann. Fam. Med. 2003. Vol. 1. № 1. Р. 8–14.

Stier D.M., Greenfield S., Lubeck D.P. et al. Quantifying comorbidity in a disease-specific cohort: adaptation of the total illness burden index to prostate cancer // Urology. 1999. Vol. 54. № 3. Р. 424–9.

Van den Akker M., Buntinx F., Metsemakers J.F. et al. Multimorbidity in general practice: prevalence, incidence, and determinants of cooccurring chronic and recurrent diseases // J. Clin. Epidemiol. 1998. № 51. Р. 367–375.

Van den Akker M, Buntinx F., Roos S., Knottnerus J.A. Comorbidity or multimorbidity: what’s in a name? A review of the literature // Eur. J. Gen. Pract. 1996. № 2. Р. 65–7.

Van Weel C., Schellevis F.G. Comorbidity and guidelines: conflicting interests // Lancet. 2006. № 367. Р. 550–551.

Walter L.C., Brand R.J., Counsell S.R. et al. Development and validation of a prognostic index for 1-year mortality in older adults after hospitalization // JAMA. 2001. Vol. 285. № 23. Р. 2987–94.

Wang P.S., Avorn J., Brookhart M.A. Effects of noncardiovascular comorbidities on antihypertensive use in elderly hypertensives // Hypertension. 2005. Vol. 46. № 2. Р. 273–279.

Wolff J.L., Starfield B., Anderson G. Prevalence, expenditures, and complications of multiple chronic conditions in elderly // Arch. Inter. Med. 2002. № 162. Р. 2269–2276.

Zhang M., Holman C.D., Price S.D. et al. Comorbidity and repeat admission to hospital for adverse drug reactions in older adults: retrospective cohort study // BMJ. 2009. № 338. a2752.

Zhang Q., Safford M., Ottenweller J. et al. Performance status of health care facilities changes with risk adjustment of HbA1c // Diabetes Care. 2000. № 23. Р. 919–27.

The authors declare that there are no conflicts of interest present.